[Adhesion molecule in pathogenesis of rheumatoid arthritis].
Origuchi
Tomoki
T
Nagasaki University School of Health Sciences.
Eguchi
Katsumi
K
D000818:Animals; D000906:Antibodies / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000494:pharmacology / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000209:etiology*; D015815:Cell Adhesion Molecules / Q000037:antagonists & inhibitors / Q000276:immunology / Q000378:metabolism / Q000502:physiology; D016207:Cytokines / Q000502:physiology; D042783:Endothelial Cells; D006801:Humans; D018836:Inflammation Mediators; D007962:Leukocytes; D008213:Lymphocyte Activation; D008562:Membrane Glycoproteins / Q000502:physiology; D010006:Osteoblasts / Q000166:cytology; D010010:Osteoclasts / Q000166:cytology; D011956:Receptors, Cell Surface / Q000502:physiology; D015398:Signal Transduction; D012995:Solubility; D013582:Synovial Fluid / Q000166:cytology; D013583:Synovial Membrane / Q000166:cytology / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology; D051193:Toll-Like Receptors
D000906:Antibodies; D018501:Antirheumatic Agents; D015815:Cell Adhesion Molecules; D016207:Cytokines; D018836:Inflammation Mediators; D008562:Membrane Glycoproteins; D011956:Receptors, Cell Surface; D051193:Toll-Like Receptors